XPeng Motors interview; Imdex ITC victory; InterDigital licensing revenues; Brazilian Oppo injunction; UPC launch confirmed; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

MONDAY 13 February

US legislators and government agencies take aim at pharma patent strategies. Read more here

A dive into Docket Navigator data revealed Cedar Lane Technologies dominated US computer centre case filings in 2022. Read more here

TUESDAY 14 February

Interview: Xpeng Motors IP director Woods Zhao gave IAM a look inside the IP strategy of the Chinese EV startup. Read more here

Indian court hands hefty fine to generic drug boss who ignored Pfizer patent injunction. Read more here

Interview: The General Counsel of Australian mining tech company Imdex spoke to IAM about its ‘intense’ US ITC victory in a global patent battle. Read more here

WEDNESDAY 15 February

Revealed: The IPBC Global 2023 agenda. Read more here

InterDigital celebrates record licensing revenues in 2022. Read more here

THURSDAY 16 February

Global tax revolution will put corporate IP strategies under far greater scrutiny. Read more here

You’ve been sued: What international patent litigants must know about US alternative service of process. Read more here

Report: IAM’s latest panel report shows the global patent market is increasingly UPC-aware but majority are considering wait-and-see approach. Read more here

FRIDAY 17 February

Exclusive: Nokia strikes blow to Oppo with Brazilian injunction. Read more here

It is confirmed: the UPC will begin on 1 June of this year. Read more here

Vidal’s ruling in Samsung v Netlist IPR may help unveil real-parties-in-interest. Read more here

SATURDAY 18 February

Opinion: Amgen v Sanofi highlights growing ambiguity of pharma IP strategies. Read more here

Unlock unlimited access to all IAM content